BR0016740A - Antìgenos de esporozoìto de cryptosporidium - Google Patents
Antìgenos de esporozoìto de cryptosporidiumInfo
- Publication number
- BR0016740A BR0016740A BR0016740-1A BR0016740A BR0016740A BR 0016740 A BR0016740 A BR 0016740A BR 0016740 A BR0016740 A BR 0016740A BR 0016740 A BR0016740 A BR 0016740A
- Authority
- BR
- Brazil
- Prior art keywords
- cryptosporidium
- antigens
- sporozoite antigens
- cryptosporidium sporozoite
- sporozoyte
- Prior art date
Links
- 241000223935 Cryptosporidium Species 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 210000003046 sporozoite Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Abstract
"ANTìGENOS DE ESPOROZOìTO DE CRYPTOSPORIDIUM". Os polipeptídeos e peptídeos antigênicos de Cryptosporidium, e moléculas de ácidos nucléicos codificando os mesmos, são descritos que têm potencial para uso em uma preparação de vacina protetora. Um polipeptídeo preferido tem a seq³ência de aminoácido. (a).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ4400A AUPQ440099A0 (en) | 1999-12-01 | 1999-12-01 | Cryptosporidium sporozoite antigens |
| PCT/AU2000/001492 WO2001040248A1 (en) | 1999-12-01 | 2000-12-01 | Cryptosporidium sporozoite antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0016740A true BR0016740A (pt) | 2002-09-03 |
Family
ID=3818542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0016740-1A BR0016740A (pt) | 1999-12-01 | 2000-12-01 | Antìgenos de esporozoìto de cryptosporidium |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030185836A1 (pt) |
| EP (1) | EP1244684A4 (pt) |
| AU (1) | AUPQ440099A0 (pt) |
| BR (1) | BR0016740A (pt) |
| CA (1) | CA2392933A1 (pt) |
| MX (1) | MXPA02005346A (pt) |
| NZ (1) | NZ519277A (pt) |
| WO (1) | WO2001040248A1 (pt) |
| ZA (1) | ZA200204831B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230015910A1 (en) | 2019-12-18 | 2023-01-19 | Intervet Inc. | Cryptosporidiosis vaccine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993024649A1 (en) * | 1992-05-29 | 1993-12-09 | The Regents Of The University Of California | Cryptosporidium polypeptides, nucleic acid, vectors and methods of use |
| US20020081312A1 (en) * | 1999-12-09 | 2002-06-27 | Priest Jeffrey W. | Recombinant cryptosporidium parvum antigen and detection of antibodies thereto |
| US6657045B1 (en) * | 2000-04-07 | 2003-12-02 | New England Medical Center Hospitals, Inc. | GP40 and uses thereof |
-
1999
- 1999-12-01 AU AUPQ4400A patent/AUPQ440099A0/en not_active Abandoned
-
2000
- 2000-12-01 EP EP00981088A patent/EP1244684A4/en not_active Withdrawn
- 2000-12-01 WO PCT/AU2000/001492 patent/WO2001040248A1/en not_active Application Discontinuation
- 2000-12-01 US US10/148,687 patent/US20030185836A1/en not_active Abandoned
- 2000-12-01 NZ NZ519277A patent/NZ519277A/en unknown
- 2000-12-01 CA CA002392933A patent/CA2392933A1/en not_active Abandoned
- 2000-12-01 MX MXPA02005346A patent/MXPA02005346A/es unknown
- 2000-12-01 BR BR0016740-1A patent/BR0016740A/pt not_active IP Right Cessation
-
2002
- 2002-06-14 ZA ZA200204831A patent/ZA200204831B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02005346A (es) | 2003-10-24 |
| ZA200204831B (en) | 2003-11-26 |
| US20030185836A1 (en) | 2003-10-02 |
| CA2392933A1 (en) | 2001-06-07 |
| EP1244684A1 (en) | 2002-10-02 |
| AUPQ440099A0 (en) | 1999-12-23 |
| EP1244684A4 (en) | 2003-05-21 |
| WO2001040248A1 (en) | 2001-06-07 |
| NZ519277A (en) | 2004-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| HUP9901186A2 (hu) | Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra | |
| CY1106350T1 (el) | Εμβολιο φυματιωσης | |
| BR9713294A (pt) | "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano" | |
| AR062300A2 (es) | Polipeptido que comprende una porcion inmunogenica de una proteina de prostata o su variante, molecula de adn, vector de expresion, celula huesped composicion farmaceutica, vacuna uso de dichas composiciones y vacunas para preparar medicamentos y proteina de fusion | |
| NZ335485A (en) | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | |
| BR9711123A (pt) | Quimeras de leucotoxina-gnrh | |
| BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
| RS51157B (sr) | Baff receptor (bcma), imunoregulatorni agens | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| CY1107706T1 (el) | Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea) | |
| BR9708220A (pt) | Peptìdios de ligação hla-a2.1 e seus usos | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| DK1219301T3 (da) | Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner | |
| AR009365A1 (es) | Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno | |
| EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
| DK0990703T3 (da) | Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf | |
| ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
| BR0016740A (pt) | Antìgenos de esporozoìto de cryptosporidium | |
| BR0212287A (pt) | Proteìna de ligação caspase-8, sua preparação e uso | |
| EP1731611A3 (en) | Eimeria hydrophilic polypeptides as vaccines | |
| DE69534738D1 (de) | Leukocyten-aktivierender Faktor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |